Concepedia

Iris Albert

IA

Statistics

Publications

16

Citations

9.6K

H-Index

15

Active since

1988

Affiliations

Amplyx Pharmaceuticals (United States)(Current)

Eloxx Pharmaceuticals (United States)

Citrix (Switzerland)

Iris Albert is an author at Amplyx Pharmaceuticals (United States) specializing in life sciences, molecular biology, and cell signaling.

Publications per year

1988–1999

16

Publications

16

Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly

Bonnee Rubinfeld, Iris Albert, Emilio Porfiri et al. · Science · 1996 · 1.4K citations

, , +17

Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines

Bonnee Rubinfeld, Paul F. Robbins, Mona El‐Gamil et al. · Science · 1997 · 1.2K citations

, , +17

Association of the <i>APC</i> Gene Product with β-Catenin

Bonnee Rubinfeld, Brian Souza, Iris Albert et al. · Science · 1993 · 1.2K citations

, , +16

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF

M Kriegler, Carl F. Perez, Kim DeFay et al. · Cell · 1988 · 1.1K citations

, , +11

Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

S Munemitsu, Iris Albert, Brígida Souza et al. · Proceedings of the National Academy of Sciences · 1995 · 1K citations

, , +14

1–5 of 16